Post-approval studies (Phase 4)Study completedNCT01184989
What this trial is testing
Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate
Who this might be right for
Arthroplasty, ReplacementPrevention of Venous ThromboembolismModerate Renal Impairment (CrCl 30-50 mL/Min)
Boehringer Ingelheim 142